Biocytogen

Biocytogen is a biotechnology and biopharmaceutical company that specializes in developing gene-targeted animal models and providing integrated solutions for antibody drug development. Founded in 2008 and headquartered in Worcester, Massachusetts, the company offers a range of services, including customized and off-the-shelf mouse models, gene-targeting services, and phenotype analysis across various fields such as metabolism, immunology, and oncology. Biocytogen's innovative platform facilitates efficient antibody drug discovery and validation through advanced gene editing technologies and a state-of-the-art animal facility. The company's core products include monoclonal antibodies YH003, targeting advanced solid tumors, and YH001, an immune checkpoint inhibitor for hepatocellular carcinoma. Biocytogen collaborates with leading pharmaceutical and biotechnology companies to accelerate research and development in the biomedical field.